Asia Pacific Microfluidics Market

To learn more about this report, Download Free Sample Report

Asia Pacific Microfluidics Market Size

The Asia-Pacific microfluidics market was valued at USD 9.22 billion in 2025. The market is estimated at USD 10.54 billion in 2026 and is projected to reach USD 30.68 billion by 2034, growing at a CAGR of 14.29% from 2026 to 2034.

MARKET DRIVERS

Growing Chronic Diseases and Technological Advancements Propel Microfluidics Market in Asia-Pacific

The increasing use of microfluidics in the healthcare industry drives the market forward in this region. Increasing chronic diseases and an aging population increase healthcare needs, which demand point-of-care (POC) testing and rapid technological changes in molecular diagnostics.

Disposable microfluidic devices are primarily used in diagnostic tools for point-of-care (POC) applications. A microfluidic device is used to detect infectious diseases detection. These devices are used for effective diagnostics tools used in hospitals, clinics, and homes. Such diagnostics tools help to control the spread of infectious diseases within the community, provide timely treatment, and effectively manage patients. Home testing cartridges have been available more recently and can be tested for flu, bacterial infection, and other diseases.

The usage of microfluidics has recently increased to detect autoimmune diseases and cancer, further accelerating the microfluidics market in the Asia-Pacific region. A microfluidic chip is developed to detect autoimmune diseases. The device detects the number of specific antibodies present in the blood. Autoimmune diseases are caused due to destruction of body tissues leading to many diseases such as lupus and rheumatoid arthritis. In addition, microfluidics is also used to detect genetic mutations in cancer, including DNA and miRNA mutations.

Growing technological advancements is another crucial factor propelling the market growth. For example, researchers have developed a microfluidic device embedded in the skin, similar to a tattoo. These microfluidics devices monitor sweat absorption from the skin and provide information based on sweating. These are used mainly by cardiovascular patients and professional athletes. This microfluidic also is used to know the heart rate, skin temperature, blood pressure, and respiratory rate.

Rising Adoption of Microfluidics in Personalized Medicine and Cancer Diagnosis

Increasing usage of microfluidics in personalized medicine also boosts the microfluidics market in the Asia-Pacific region. Microfluidics plays a significant role in personalized medicine. These personalized medicines are used to make medical decisions, practices, and medicine for individual patients based on their predicted disease risk. Microfluidic technology controls and allows researchers to make the correct decisions in manufacturing the proper treatment for the patient and individualized drug therapy. In addition, microfluidics is an excellent way to cancer diagnosis. Microfluidics is used for detecting cancer at a low cost and in a sensitive approach to give an accurate result.

MARKET RESTRAINTS

Painful Catheterization and Alternative Treatments Restrict Market Adoption

The lack of skilled professionals and high costs associated with the devices hamper the market growth in this region. In addition, inaccurate results in some biomedical applications further impede the market growth.

REPORT COVERAGE

COUNTRY LEVEL ANALYSIS

Geographically, the Asia-Pacific is one of the promising regions for microfluidics worldwide. Asia Pacific region held the second largest share of the global market in 2025, owing to advancements in microfluidics in various sectors. China holds the maximum market share in this region. Chinese microfluidic device manufacturers have been increasing recently. Chinese has done several types of research in the development of healthcare with this microfluidics for the betterment of healthcare outcomes. Several local governments have created several research centers for this microfluidics. The Chinese industrial microfluidic is used in various applications such as drug delivery, food safety, environmental control, microreactors, R&D instrumentation, etc.

In India, microfluid is used in IVF treatment. This is a new technique in sperm processing and separation method. It helps to get the sperms without damaging the sperms and without causing DNA fragmentation which drives the microfluidics market in this region.

In 2021, Japanese chemical company DAICEL announced that it to provide an innovative microfluidic system. In addition, microfluidic devices are used in various types of plant cell research. All these factors drive the market forward in the Asia Pacific region.

KEY MARKET PLAYERS

Some of the noteworthy companies operating in the Asia Pacific microfluidics market profiled in this report are Parker-Hannifin Corporation, SMC Corporation, Idex Corporation, Fluigent SA, Dolomite Microfluidics, Aignep S.P.A., Camozzi Automation Spa Società Unipersonale, Elveflow, Cellix Ltd., Fortive Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Perkinelmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson And Company, Illumina, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation and Abbott Laboratories.

MARKET SEGMENTATION

This market research report on the Asia Pacific microfluidics market has been segmented and sub-segmented following categories.

By Product

• Microfluidic devices
• Microfluidic components

By Industry

• In-vitro diagnostics
• Pharmaceutical
• Medical devices
• Others

By Material

• Polymer
• Glass
• Silicon
• Others

By Application

• Lab-on-a-chip
• Organs-on-chips
• Continuous flow
• Optofluidics
• Acoustofluidics
• Electrophoresis

By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of Asia Pacific